BRIEF-Edgewise Therapeutics Inc On Track To Deliver Full 12-Week Part D Readout In 2Q 2026 And Phase 3 Start In 4Q 2026
Reuters
Yesterday
BRIEF-Edgewise Therapeutics Inc On Track To Deliver Full 12-Week Part D Readout In 2Q 2026 And Phase 3 Start In 4Q 2026
Dec 24 (Reuters) - Edgewise Therapeutics Inc EWTX.O:
EDGEWISE THERAPEUTICS INC: ON TRACK TO DELIVER FULL 12-WEEK PART D READOUT IN 2Q 2026 AND PHASE 3 START IN 4Q 2026
EDGEWISE THERAPEUTICS INC - COMPLETES PHASE 2 PARTS B AND C OF CIRRUS-HCM
EDGEWISE THERAPEUTICS INC - EDG-7500 WELL TOLERATED WITH NO SIGNIFICANT LVEF REDUCTIONS
Source text: ID:nPn5nLldTa
Further company coverage: EWTX.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.